A report from this month's Chair, Elin about what was discussed. Read more
We're looking for a qualified accountant with charity experience to join our board as treasurer. Read more
A report from this month's Chair, Lily about what was discussed. Read more
Many of you have been asking for an update on our research into the efficacy of the vaccine for aplastic anaemia patients. Here's a short update on what's going on. Read more
On 12 August 2021, the first meeting of The AAT Youth Board took place. Here's what was discussed... Read more
We visited the family to see their reaction to Super-Rare Max! Read more
JCVI have issued updated guidance about the Covid-19 vaccine for immunocompromised children and young people, and those who live with an immunocompromised person. Read the latest advice here. Read more
The together for healthy marrow alliance has published an open letter to the chief medical officers asking them to reconsider the easing of restrictions because of the profound impact it will have on our patient communities. Read the letter in full here. Read more
The Aplastic Anaemia Trust is looking for young people with experience of aplastic anaemia to join our new youth board. Read more
Are you a fantastic grant application writer with an interest in developing your skills in evidence gathering? You could be our Fundraising and Evidence Manager! Read more
The Aplastic Anaemia Trust and PNH Support are very pleased to share the news that ravulizumab has now been recommended for use in the NHS as treatment for adults with Paroxysmal Nocturnal Haemoglobinuria (PNH). Read more
We understand that the recent news reports about the Covid vaccine’s efficacy for cancer patients and those with a compromised immune system will be concerning for our patient community. We would like to update you with what we know so far, and what we’re doing to find out more. Read more
Merv Lawrence was diagnosed with Very Severe Aplastic Anaemia in 2007. He's launched a mega fundraising campaign to give something back: Love You To The Moon and Back. Read more
Patients whose severe aplastic anaemia has not responded to immunosuppressive therapy, or who have relapsed, are invited to enquire about joining the trial to assess the safety of a brand new treatment. Read more
We asked our community what they wanted people to know about aplastic anaemia. Here's what they said... Read more
The new study will shed light on the question of how effective the Covid-19 vaccines are in aplastic anaemia patients. Read more
Do you get a kick out of someone else’s joy as they reach their fundraising target? Are you an excellent communicator online and on the phone? You could be our next Supporter Experience Assistant... Read more
When Carole Fleming fell ill while on holiday in Turkey with a mysterious illness, her family faced a fight to raise the money to bring her home. But a u-turn from their insurance company put them in a position to make a huge contribution to our work. Read more
Top wellbeing tips from our Wellbeing Webinars with Lesley! Try these to help you feel better... Read more
Browse our brand new resources for children and young people affected by aplastic anaemia, and their families and friends. Read more
The Aplastic Anaemia Trust is delighted to have partnered with Maggies to bring you a series of helpful webinars. Read more
We're looking for gorgeous gifts from small independent sellers, to give our Christmas Market a touch of magic! Here's how you can get involved... Read more
From discussions in our expert webinar series and our recent patient survey, we know that the potential vaccine for Covid-19 is a topic of much conversation among our patient community. After a discussion at our recent trustee meeting, we wanted to share our knowledge with you. Read more
One of the effects of the coronavirus health crisis has been that AA patients who would otherwise be candidates for a transplant are unable to have one. Our patient advocacy on this issue has led to the drug eltrombopag being made rapidly available for these patients, and for severe AA patients who have previously failed to respond to ATG/ciclosporin. Read more